Literature DB >> 6263965

Androblastoma: pre-, per- and post-operative steroid hormone and binding protein concentrations in peripheral plasma, cyst fluid and tumor vein.

P H Rolland, P M Martin, A M Rolland, F Laffargue, H Serment.   

Abstract

A case-report of arrhenoblastoma is presented where the endocrine profile has been determined before, during and after removal of the tumor. Sex steroids, cortisol, corticosteroid binding globulin (CBG) and sex steroid binding protein (SBP) were measured in fluid from 2 cysts, tumor vein and peripheral plasma. Hormones were measures by specific RIAs after stepwise chromatography on celite support according to a new elution pattern allowing the resolution of 8 sex steroid in a single chromatographic system. Excessive amounts of androgen, the most prominent being testosterone, and 17-OH-progesterone, but low levels of estrogens and progesterone were found in preoperative plasma. Due to an androgen-directed rise of CBG, large amounts of plasma cortisol were detected. However, preoperative SBP capacity was found to be reduced. The steroid profile of cyst fluids was found to be similar to that of peripheral plasma. Neoplastic cells were found capable of producing an androgen binding protein. These results correlated well with Sertoli-Leydig cell tumors histology, i.e. a testis-like endocrine structure. From the endocrine profile, the steroid biosynthetic pathways are discussed with respect to the possibility that biosynthesis, once the 17-OH-pregnenolone structure was reached, was active along both the delta 5 and delta 4-steroid pathways. The steroid levels in tumor vein and their corresponding gradients to the periphery are discussed with respect to: i) the possibility of metabolic and biosynthetic capacities of cancer cells bearing an undifferentiated steroidogenic appearance, ii) the possibility for tumor steroid secretion by others means than by venous blood and iii) the possibility that both point i) and ii) could be the cause of inconsistent diagnosis significant of endocrine profile as observed in some patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263965     DOI: 10.1007/BF03349409

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  39 in total

1.  Formation of androgens by human arrhenoblastoma tissue in vitro.

Authors:  K SAVARD; M GUT; R I DORFMAN; J L GABRILOVE; L J SOFFER
Journal:  J Clin Endocrinol Metab       Date:  1961-02       Impact factor: 5.958

2.  Arrhenoblastoma: in vivo and in vitro studies.

Authors:  E V Younglai; H Richmond; R Atyeo; F L Johnson
Journal:  Am J Obstet Gynecol       Date:  1973-06-01       Impact factor: 8.661

3.  Arrhenoblastoma: three case reports.

Authors:  R B Greenblatt; V B Mahesh; R D Gambrell
Journal:  Obstet Gynecol       Date:  1972-04       Impact factor: 7.661

4.  A clinical and metabolic study of masculinizing arrhenoblastoma.

Authors:  T Sato; T Shinada; S Matsumoto
Journal:  Am J Obstet Gynecol       Date:  1969-08-15       Impact factor: 8.661

5.  Metabolism of testosterone by virilizing Krukenberg tumor of the ovary.

Authors:  I G Ances; F M Ganis
Journal:  Am J Obstet Gynecol       Date:  1968-04-15       Impact factor: 8.661

6.  Masculinizing tumor of the ovary, apparently with adrenocortical activity. A histologic, ultrastructural, and biochemical study.

Authors:  L G Koss; E O Rothschild; M Fleisher; J E Francis
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

7.  High-affinity binding of progesterone, testosterone and cortisol in normal and androgen-treated guinea pigs during various reproductive stages: relationship to masculinization.

Authors:  M Diamond; N Rust; U Westphal
Journal:  Endocrinology       Date:  1969-05       Impact factor: 4.736

8.  Routine analysis of multiple steroid receptors in human breast cancer.--I--Technological features.

Authors:  P M Martin; P H Rolland; J Jacquemier; A M Rolland; M Toga
Journal:  Biomedicine       Date:  1978-10

9.  Human testosterone-oestradiol binding globulin in health and disease.

Authors:  R V Wenn; I A Kamberi; P Vossough; M H Kariminejad; E Torabee; M Keyvanjah; N Sarberi
Journal:  Acta Endocrinol (Copenh)       Date:  1977-04

10.  An immunohistological study of steroid localization in Sertoli-Leydig tumors of the ovary and testis.

Authors:  R J Kurman; D Andrade; U Goebelsmann; C R Taylor
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

View more
  2 in total

1.  Hirsutism caused by an androgen-producing ovarian tumor. A case of arrhenoblastoma.

Authors:  O Lunde; O Djoseland
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

2.  Ovarian and peripheral steroid hormones in a case of Sertoli-Leydig cell tumor.

Authors:  D Mango; P Scirpa; M Liberati; E Menini; A Fabiano; S Mancuso
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.